{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T10:17:44Z","timestamp":1789208264844,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["435224\/2018-2"],"award-info":[{"award-number":["435224\/2018-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-00931-18"],"award-info":[{"award-number":["APQ-00931-18"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-02556-18"],"award-info":[{"award-number":["APQ-02556-18"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-02638-17"],"award-info":[{"award-number":["APQ-02638-17"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["PRONEX APQ-01373-14"],"award-info":[{"award-number":["PRONEX APQ-01373-14"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009730","name":"Universidade Federal de Ouro Preto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009730","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.vaccine.2022.08.005","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T16:17:16Z","timestamp":1660148236000},"page":"5494-5503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Immunoprophylaxis using polypeptide chimera vaccines plus adjuvant system promote Th1 response controlling the spleen parasitism in hamster model of visceral leishmaniasis"],"prefix":"10.1016","volume":"40","author":[{"given":"Miri\u00e3 Rodrigues","family":"Gusm\u00e3o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tha\u00eds Lopes Valentim Di Paschoali","family":"Ostolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edvia Mendes","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Fl\u00e1via Pereira","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Jos\u00e9 Lucas","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamille Mirelle de Oliveira","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Dian de Oliveira","family":"Aguiar-Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Barbosa","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory Cristiane Fortes","family":"de Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Mendes","family":"Roatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"34","key":"10.1016\/j.vaccine.2022.08.005_b0005","doi-asserted-by":"crossref","first-page":"12283","DOI":"10.1073\/pnas.1400472111","article-title":"History of vaccination","volume":"111","author":"Plotkin","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2022.08.005_b0010","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.rmr.2018.02.015","article-title":"History and principles of vaccination","volume":"36","author":"Canou\u00ef","year":"2019","journal-title":"Rev Mal Respir"},{"issue":"10111","key":"10.1016\/j.vaccine.2022.08.005_b0015","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/S0140-6736(17)31463-0","article-title":"Measles","volume":"390","author":"Moss","year":"2017","journal-title":"Lancet"},{"issue":"9984","key":"10.1016\/j.vaccine.2022.08.005_b0020","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/S0140-6736(14)60539-0","article-title":"Rubella","volume":"385","author":"Lambert","year":"2015","journal-title":"Lancet"},{"issue":"10181","key":"10.1016\/j.vaccine.2022.08.005_b0025","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0140-6736(18)33131-3","article-title":"Tetanus","volume":"393","author":"Yen","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2022.08.005_b0030","article-title":"Diphtheria","volume":"5","author":"Sharma","year":"2019","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.vaccine.2022.08.005_b0035","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2217\/fmb.15.19","article-title":"Polio vaccination: Past, present and future","volume":"10","author":"Bandyopadhyay","year":"2015","journal-title":"Future Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2022.08.005_b0040","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.idc.2015.07.003","article-title":"The Challenge of Global Poliomyelitis Eradication","volume":"29","author":"Garon","year":"2015","journal-title":"Infect Dis Clin North Am"},{"issue":"6","key":"10.1016\/j.vaccine.2022.08.005_b0045","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1016\/S2666-5247(20)30152-X","article-title":"Africa eradicates wild polio","volume":"1","author":"Makoni","year":"2020","journal-title":"The Lancet Microbe"},{"key":"10.1016\/j.vaccine.2022.08.005_b0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2022.08.005_b0055","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4155\/bio-2017-0176","article-title":"Principles of vaccine potency assays","volume":"10","author":"Verch","year":"2018","journal-title":"Bioanalysis"},{"issue":"2","key":"10.1016\/j.vaccine.2022.08.005_b0060","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cvsm.2017.10.002","article-title":"Recent advances in vaccine technologies","volume":"48","author":"Francis","year":"2018","journal-title":"Vet Clin North Am Small Anim Pr"},{"key":"10.1016\/j.vaccine.2022.08.005_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.583077","article-title":"Emerging Concepts and Technologies in Vaccine Development","volume":"11","author":"Brisse","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2022.08.005_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.608460","article-title":"RNA Vaccines: A Suitable Platform for Tackling Emerging Pandemics?","volume":"11","author":"Sandbrink","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2022.08.005_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-020-00695-2","article-title":"Coronavirus vaccine development: from SARS and MERS to COVID-19","volume":"27","author":"Li","year":"2020","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.vaccine.2022.08.005_b0080","first-page":"265","article-title":"Global leishmaniasis surveillance, 2017\u20132018, and first report on 5 additional indicators","volume":"95","author":"World Health Organization","year":"2020","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2022.08.005_b0085","unstructured":"PAHO. Leishmaniasis: Epidemiological Report of the Americass No 7 - Mar\u00e7o, 2019. Inf. Leishmanioses No 7 1, 1\u201327 (2019)."},{"key":"10.1016\/j.vaccine.2022.08.005_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2014.00380","article-title":"Visceral leishmaniasis: Advancements in vaccine development via classical and molecular approaches","volume":"5","author":"Joshi","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2022.08.005_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01043","article-title":"Peptide vaccines for leishmaniasis","volume":"9","author":"De Brito","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2022.08.005_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2019.103704","article-title":"Genome based screening of epitope ensemble vaccine candidates against dreadful visceral leishmaniasis using immunoinformatics approach","volume":"136","author":"Singh","year":"2019","journal-title":"Microb Pathog"},{"issue":"4","key":"10.1016\/j.vaccine.2022.08.005_b0105","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ymeth.2004.06.004","article-title":"From genome to vaccine - New immunoinformatics tools for vaccine design","volume":"34","author":"De Groot","year":"2004","journal-title":"Methods"},{"issue":"6","key":"10.1016\/j.vaccine.2022.08.005_b0110","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.micinf.2017.03.002","article-title":"Immuno-informatics based approaches to identify CD8+ T cell epitopes within the Leishmania donovani 3-ectonucleotidase in cured visceral leishmaniasis subjects","volume":"19","author":"Vijayamahantesh","year":"2017","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2022.08.005_b0115","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ijbiomac.2018.08.125","article-title":"Immunoinformatics-aided design of a potential multi-epitope peptide vaccine against Leishmania infantum","volume":"120","author":"Vakili","year":"2018","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.vaccine.2022.08.005_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms18020371","article-title":"Immunoinformatics features linked to Leishmania vaccine development: Data integration of experimental and in silico studies","volume":"18","author":"Brito","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.vaccine.2022.08.005_b0125","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3390\/vaccines7040162","article-title":"Synthetic peptides elicit strong cellular immunity in visceral leishmaniasis natural reservoir and contribute to long-lasting polyfunctional T-cells in BALB\/c mice","volume":"7","author":"De Brito","year":"2019","journal-title":"Vaccines"},{"issue":"20","key":"10.1016\/j.vaccine.2022.08.005_b0130","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1016\/j.vaccine.2021.04.004","article-title":"A chimeric vaccine combined with adjuvant system induces immunogenicity and protection against visceral leishmaniasis in BALB\/c mice","volume":"39","author":"Ostolin","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.08.005_b0135","first-page":"439","article-title":"Animal models for vaccine studies for visceral leishmaniasis","volume":"123","author":"Garg","year":"2006","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.vaccine.2022.08.005_b0140","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0165-2427(00)00221-X","article-title":"Immune and clinical parameters associated with Leishmania infantum infection in the golden hamster model","volume":"76","author":"Requena","year":"2000","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2022.08.005_b0145","doi-asserted-by":"crossref","unstructured":"Moreira, N. das D. et al. Parasite Burden in Hamsters Infected with Two Different Strains of Leishmania (Leishmania) infantum: \u2018Leishman Donovan Units\u2019 versus Real-Time PCR. PLoS One 7, 1\u201311 (2012).","DOI":"10.1371\/journal.pone.0047907"},{"issue":"1","key":"10.1016\/j.vaccine.2022.08.005_b0150","doi-asserted-by":"crossref","DOI":"10.1186\/s13071-016-1464-y","article-title":"Clinical, hematological and biochemical alterations in hamster (Mesocricetus auratus) experimentally infected with Leishmania infantum through different routes of inoculation","volume":"9","author":"Moreira","year":"2016","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.vaccine.2022.08.005_b0155","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12768","article-title":"Hamster, a close model for visceral leishmaniasis: Opportunities and challenges","volume":"42","author":"Saini","year":"2020","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2022.08.005_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/pim.12823","article-title":"Establishment of monoclonal antibodies to evaluate the cellular immunity in a hamster model of L infantum infection","volume":"43","author":"Carvalho","year":"2021","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2022.08.005_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0003490","article-title":"Vaccination with Leishmania infantum Acidic Ribosomal P0 but Not with Nucleosomal Histones Proteins Controls Leishmania infantum Infection in Hamsters","volume":"9","author":"Pereira","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2022.08.005_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0004322","article-title":"Intradermal Immunization of Leishmania donovani Centrin Knock-Out Parasites in Combination with Salivary Protein LJM19 from Sand Fly Vector Induces a Durable Protective Immune Response in Hamsters","volume":"10","author":"Fiuza","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2022.08.005_b0175","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/cei.12780","article-title":"Immunoprotective responses of T helper type 1 stimulatory protein-S-adenosyl-L-homocysteine hydrolase against experimental visceral leishmaniasis","volume":"185","author":"Khare","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2022.08.005_b0180","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1673-8527(09)60086-2","article-title":"Identification and expression analysis of mical family genes in zebrafish","volume":"37","author":"Xue","year":"2010","journal-title":"J Genet Genomics"},{"key":"10.1016\/j.vaccine.2022.08.005_b0185","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.rvsc.2005.09.011","article-title":"Parasite density and impaired biochemical\/hematological status are associated with severe clinical aspects of canine visceral leishmaniasis","volume":"81","author":"Reis","year":"2006","journal-title":"Res Vet Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2022.08.005_b0190","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-020-00279-z","article-title":"Protective efficacy of a SARS-CoV-2 DNA vaccine in wild-type and immunosuppressed Syrian hamsters","volume":"6","author":"Brocato","year":"2021","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2022.08.005_b0195","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/jac\/dkr485","article-title":"Treatment of leishmania donovani-infected hamsters with miltefosine: Analysis of cytokine mRNA expression by real-time PCR, lymphoproliferation, nitrite production and antibody responses","volume":"67","author":"Gupta","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.vaccine.2022.08.005_b0200","doi-asserted-by":"crossref","first-page":"e3439","DOI":"10.1371\/journal.pntd.0003439","article-title":"Intranasal Vaccination with Leishmanial Antigens Protects Golden Hamsters (Mesocricetus auratus) Against Leishmania (Viannia) braziliensis Infection","volume":"9","author":"da Silva-Couto","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2022.08.005_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetpar.2009.05.022","article-title":"Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis","volume":"165","author":"Solano-Gallego","year":"2009","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2022.08.005_b0210","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.vetimm.2008.10.307","article-title":"Systemic and compartmentalized immune response in canine visceral leishmaniasis","volume":"128","author":"Reis","year":"2009","journal-title":"Vet Immunol Immunopathol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.08.005_b0215","doi-asserted-by":"crossref","first-page":"e12359","DOI":"10.1111\/pim.12359","article-title":"A recombinant chimeric protein composed of human and mice-specific CD4+ and CD8+ T-cell epitopes protects against visceral leishmaniasis","volume":"39","author":"Martins","year":"2017","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2022.08.005_b0220","doi-asserted-by":"crossref","unstructured":"Murray HW, Stern JJ, Welte K, Rubin BY, C SM, N. CF. No Title. J. Immunol. 138, 2290\u20132297 (1987).","DOI":"10.4049\/jimmunol.138.7.2290"},{"issue":"10","key":"10.1016\/j.vaccine.2022.08.005_b0225","doi-asserted-by":"crossref","first-page":"e845","DOI":"10.1371\/journal.pntd.0000845","article-title":"CD8+ T cells as a source of IFN-\u03b3 production in human cutaneous leishmaniasis","volume":"4","author":"Nateghi Rostami","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2022.08.005_b0230","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1006\/cyto.2000.0694","article-title":"IL-10 and IL-12 are the main regulatory cytokines in visceral leishmaniasis","volume":"12","author":"Bacellar","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.vaccine.2022.08.005_b0235","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-3083.2007.02025.x","article-title":"Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB\/c mice","volume":"66","author":"Dey","year":"2007","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2022.08.005_b0240","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4049\/jimmunol.1700674","article-title":"Live Attenuated Leishmania donovani Centrin Gene-Deleted Parasites Induce IL-23\u2013Dependent IL-17\u2013Protective Immune Response against Visceral Leishmaniasis in a Murine Model","volume":"200","author":"Banerjee","year":"2018","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2022.08.005_b0245","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3390\/vaccines8040690","article-title":"Phase i and ii clinical trial comparing the lbsap, leishmune\u00ae, and leish-tec\u00ae vaccines against canine visceral leishmaniasis","volume":"8","author":"Aguiar-Soares","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2022.08.005_b0250","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.vetimm.2008.11.020","article-title":"Expression of IFN-\u03b3, TNF-\u03b1, IL-10 and TGF-\u03b2 in lymph nodes associates with parasite load and clinical form of disease in dogs naturally infected with Leishmania (Leishmania) chagasi","volume":"128","author":"Alves","year":"2009","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2022.08.005_b0255","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.rvsc.2008.12.009","article-title":"Evidence for a relationship between Leishmania load and clinical manifestations","volume":"87","author":"Manna","year":"2009","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2022.08.005_b0260","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.4049\/jimmunol.166.3.1912","article-title":"The Hamster as a Model of Human Visceral Leishmaniasis: Progressive Disease and Impaired Generation of Nitric Oxide in the Face of a Prominent Th1-Like Cytokine Response","volume":"166","author":"Melby","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2022.08.005_b0265","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1297-9716-42-39","article-title":"Mechanisms of resistance and susceptibility to experimental visceral leishmaniosis: BALB\/c mouse versus syrian hamster model","volume":"42","author":"Nieto","year":"2011","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2022.08.005_b0270","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.micpath.2004.11.002","article-title":"Immunopathogenesis of infection with the visceralizing Leishmania species","volume":"38","author":"Wilson","year":"2005","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2022.08.005_b0275","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.20041470","article-title":"A role for IgG immune complexes during infection with the intracellular pathogen Leishmania","volume":"201","author":"Miles","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2022.08.005_b0280","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12783","article-title":"Status of IL-4 and IL-10 driven markers in experimental models of Visceral Leishmaniasis","volume":"43","author":"Moulik","year":"2021","journal-title":"Parasite Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.08.005_b0285","doi-asserted-by":"crossref","first-page":"e1003053","DOI":"10.1371\/journal.ppat.1003053","article-title":"Determinants for the Development of Visceral Leishmaniasis Disease","volume":"9","author":"McCall","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2022.08.005_b0290","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1590\/S0100-879X2004000400020","article-title":"Immunity and immunosuppression in experimental visceral leishmaniasis","volume":"37","author":"Goto","year":"2004","journal-title":"Brazilian J Med Biol Res"},{"key":"10.1016\/j.vaccine.2022.08.005_b0295","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2307\/3276733","article-title":"Course of Infection of Leishmania donovani in Hamsters Inoculated by the Intraperitoneal Route","volume":"53","author":"Ott","year":"1967","journal-title":"J Parasitol"},{"key":"10.1016\/j.vaccine.2022.08.005_b0300","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.exppara.2019.04.012","article-title":"Verification and monitoring of visceral leishmaniasis in hamsters caused by Leishmania infantum, using non-invasive approaches involving ultrasound imaging and blood gases","volume":"201","author":"Murillo","year":"2019","journal-title":"Exp Parasitol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22009616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22009616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:15:56Z","timestamp":1759403756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22009616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":60,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0264410X22009616"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.08.005","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunoprophylaxis using polypeptide chimera vaccines plus adjuvant system promote Th1 response controlling the spleen parasitism in hamster model of visceral leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}